Singapore markets closed

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
258.06+14.49 (+5.95%)
At close: 04:00PM EDT
259.79 +1.73 (+0.67%)
After hours: 07:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close243.57
Bid248.00 x 1000
Ask260.00 x 1100
Day's range244.43 - 258.07
52-week range208.35 - 526.00
Avg. volume956,269
Market cap40.541B
Beta (5Y monthly)0.99
PE ratio (TTM)56.65
EPS (TTM)4.55
Earnings date03 Aug 2022 - 08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est358.56
  • Reuters

    EU court to rule July 13 on Illumina challenge of EU review of Grail -sources

    A European court will decide on July 13 whether U.S. life sciences company Illumina's $8 billion cash-and-stock takeover of Grail should be scrutinised by EU antitrust regulators, people familiar with the matter said on Wednesday. The case coincides with the European Commission seeking to expand its power to examine big companies' acquisitions of start-ups aimed at shutting down nascent rivals, with the focus on tech and pharma deals. The Luxembourg-based General Court, Europe's second-top court, declined to comment on the date of its ruling.

  • Zacks

    Illumina (ILMN) to Offer Companion Diagnostic for VITRAKVI

    Illumina's (ILMN) first companion diagnostic claim for TSO Comprehensive (EU) will help identify cancer patients with NTRK gene fusions for a genomically matched treatment.

  • Zacks

    Illumina's (ILMN) Innovations Drive Growth, Cost Woes Linger

    Illumina (ILMN) is working on its goals to strengthen its foothold in the multi-billion gene sequencing market with some highly competitive products in its existing portfolio and pipeline.